AI assistant
Vericel Corp — Director's Dealing 2020
Oct 2, 2020
31799_dirs_2020-10-02_5d601d7d-86d7-4c81-aba6-0a3d1689edbb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2020-09-30
Reporting Person: Pennell Sandra (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3440 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $2.65 | 2027-05-22 | Common Stock (3300) | Direct | |
| Stock Option (right to buy) | $18.51 | 2029-03-20 | Common Stock (10822) | Direct | |
| Stock Option (right to buy) | $18.51 | 2029-03-20 | Common Stock (9178) | Direct | |
| Stock Option (right to buy) | $11.10 | 2028-03-21 | Common Stock (21000) | Direct | |
| Stock Option (right to buy) | $7.25 | 2030-03-18 | Common Stock (10312) | Direct | |
| Stock Option (right to buy) | $7.25 | 2030-03-18 | Common Stock (4688) | Direct | |
| Stock Option (right to buy) | $4.61 | 2026-03-18 | Common Stock (7900) | Direct | |
| Stock Option (right to buy) | $2.90 | 2027-03-17 | Common Stock (7700) | Direct | |
| Stock Option (right to buy) | $3.63 | 2025-02-11 | Common Stock (20000) | Direct | |
| Restricted Stock Unit | $ | Common Stock (1500) | Direct | ||
| Restricted Stock Unit | $ | Common Stock (2000) | Direct |
Footnotes
F1: These options began vesting on March 17, 2017 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
F2: These options began vesting on March 20, 2019 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
F3: These options began vesting on March 21, 2018 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
F4: These options began vesting on March 18, 2020 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
F5: These options began vesting on March 18, 2016 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
F6: These options, representing the right to purchase 20,000 shares, became exercisable on February 11, 2016, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter.
F7: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
F8: These RSUs vest in four annual installments. The first installment of RSUs vested on March 20, 2020 and are shown in the holdings reported in Table I. The remaining 1,500 RSUs will vest in annual installments on March 20, 2021, March 20, 2022, and March 20, 2023, respectively.
F9: No expiration date for this type of award.
F10: These RSUs vest in four annual installments with 500 RSUs vesting on March 18, 2021, March 18, 2022, March 18, 2023 and March 18, 2024, respectively.